Protara Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
/ 
Frequently asked questions
To buy Protara Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Protara Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Protara Therapeutics Inc. is TARA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Protara Therapeutics Inc. has its primary listing on NASDAQ. You can trade Protara Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Protara Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Protara Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Protara Therapeutics Inc. or others.